TGF-β-induced ganglioside remodeling highlights GD2 as a dynamically regulated target in glioblastoma
Year: 2026
Type: article
Abstract: Glioblastoma (GBM) is characterized by extensive cellular plasticity and dynamic interactions with the tumor microenvironment. The tumor-associated ganglioside GD2 is considered a promising therapeutic target, although its stability across different cellular states remains unclear. Here, we investigated whether transforming growth factor-β (TGF-β), a key regulator of glioblastoma progression and mesenchymal reprogramming, modulates ganglioside-biosynthetic gene expression and GD2 surface expression. Using U87-MG and U251-MG glioblastoma cell lines, we combined MALDI–TOF-MS glycosphingolipid profiling, flow cytometry, quantitative PCR, Western blot analysis, and migration assays to characterize TGF-β–induced phenotypic changes. Baseline analyses revealed marked differences in ganglioside composition between the two cell lines. TGF-β induced distinct mesenchymal-like phenotypic responses and differentially regulated ganglioside-biosynthetic gene expression, resulting in opposite effects on GD2 surface expression: GD2 levels increased in U251-MG cells but decreased in U87-MG cells. These changes were accompanied by cell line–specific alterations in migratory behavior. Pharmacological inhibition of UDP-glucose ceramide glucosyltransferase (UGCG) reduced GD2 expression and attenuated migration, supporting a broader contribution of glycosphingolipid biosynthesis to migratory behavior. Together, these findings demonstrate that GD2 expression is dynamically regulated by microenvironmental signaling and is associated with TGF-β-induced phenotypic changes in the glioblastoma cell models examined. Our results identify changes in ganglioside-biosynthetic gene expression and GD2 surface abundance as molecular features accompanying tumor cell plasticity and suggest that GD2 should be considered a context-dependent therapeutic target rather than a stable tumor-associated marker.
Source: Scientific Reports
Institutions: Semmelweis University, Centre National de la Recherche Scientifique, Université de Lille, Unité de Glycobiologie Structurale et Fonctionnelle, Inserm, Centre Hospitalier Universitaire de Lille, Centre de Recherches en Cancérologie de Lille, Multidisciplinary International Research for Advancing Innovation in Glycosciences, Nagoya University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7225017404
